共 44 条
Facile synthesis of novel substituted aryl-thiazole (SAT) analogs via one-pot multi-component reaction as potent cytotoxic agents against cancer cell lines
被引:21
|作者:
Mirza, Salma
[1
]
Naqvi, Syeda Asma
[2
]
Khan, Khalid Mohammed
[1
]
Salar, Uzma
[1
]
Choudhary, M. Iqbal
[1
,2
,3
]
机构:
[1] Univ Karachi, Int Ctr Chem & Biol Sci, HEJ Res Inst Chem, Karachi 75270, Pakistan
[2] Univ Karachi, Int Ctr Chem & Biol Sci, Dr Panjwani Ctr Mol Med & Drug Res, Karachi 75270, Pakistan
[3] King Abdulaziz Univ, Fac Sci, Dept Biochem, Jeddah 21412, Saudi Arabia
关键词:
Thiazole;
Characterization;
Anticancer agents;
(MCF7;
MDA-MB-231);
(HCT-116);
(HeLa);
Cytotoxicity;
2-ARYLTHIAZOLIDINE-4-CARBOXYLIC ACID-AMIDES;
ANTICANCER AGENTS;
BIOLOGICAL EVALUATION;
ANTITUMOR-ACTIVITY;
THIOUREA COMPOUNDS;
PROSTATE-CANCER;
BREAST-CANCER;
IN-VITRO;
DERIVATIVES;
INHIBITORS;
D O I:
10.1016/j.bioorg.2016.12.003
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
In this study, twenty-five (25) substituted aryl thiazoles (SAT) 1-25 were synthesized, and their in vitro cytotoxicity was evaluated against four cancer cell lines, MCF-7 (ER+ve breast), MDA-MB-231 (ER (ve) breast), HCT116 (colorectal) and HeLa (cervical). The activity was compared with the standard anticancer drug doxorubicin (IC50 = 1.56 +/- 0.05 mu M). Among them, compounds 1, 4-8, and 19 were found to be toxic to all four cancer cell lines (IC50 values 5.37 +/- 0.56-46.72 +/- 1.80 mu M). Compound 20 was selectively active against MCF7 breast cancer cells with IC50 of 40.21 +/- 4.15 mu M, whereas compound 19 was active against MCF7 and HeLa cells with IC50 of 46.72 +/- 1.8, and 19.86 +/- 0.11 mu M, respectively. These results suggest that substituted aryl thiazoles 1 and 4 deserve to be further investigated in vivo as anticancer leads. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:133 / 143
页数:11
相关论文